LSBCF and LSBWF Related Headlines
Go Back- LakeShore Biopharma receives revised $0.06 per share buyout proposal
- LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company
- LakeShore Biopharma postpones shareholder meeting amid merger dispute
- LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders
- LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
- LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction
- LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting
LSBCF and LSBWF Related Press Releases
Go Back- LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company
- LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders
- LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
- LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction
- LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting
